Spruce Biosciences, Inc. (SPRB) Tops Q1 EPS by 8c

Spruce Biosciences, Inc. (NASDAQ: SPRB) reported Q1 EPS of ($0.28), $0.08 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $2 million versus the consensus estimate of $1.3 million.

For earnings history and earnings-related data on Spruce Biosciences, Inc. (SPRB) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Jersey Mike's Subs (JMKE) PT Raised to $30 at Tigress Financial Partners
• DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print